About Vaxxinity

Vaxxinity, Inc. is a U.S.-based, clinical stage biotechnology company, that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. Vaxxinity has a proprietary technology platform that has enabled the innovation of synthetic peptide vaccines designed to treat and prevent chronic diseases, including Alzheimer's, Parkinson's, migraine, and hypercholesterolemia, as well as infectious diseases, including COVID-19. Vaxxinity has designed its pipeline to achieve a histor

Repeat Founder
Elite School Alumni
Company Highlights
Year Founded

2019

icon-altEmployees

61

Location (HQ)

USA

Since Last Funding

2 years 5 months

Monthly Website Visitors

22.7K

icon-altTotal Investment Amt

$9.3M

Last Funding Round

Grant

icon-altMoM Headcount Growth

-4.68%

icon-altYoY Headcount Growth

-29.85%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Medical

Biotechnology

Biotechnology Research

Pharmaceutical